“Investigator Global Assessment (IGA) of Acne Vulgaris and IGA Success Among Patients With Moderate to Severe Non-Nodular Acne Vulgaris (AV) Administered Sarecycline in Community Practices across the U.S: PROSES Study Analysis by Gender and Age”. 2023. SKIN The Journal of Cutaneous Medicine 7 (2): s156. https://doi.org/10.25251/skin.7.supp.156.